Extracorporeal photopheresis: how, why and for whom?-Reference-Cited by-同舟云学术

Extracorporeal photopheresis: how, why and for whom?

Published:2023-05-12 Issue:2 Volume:22 Page:159-165
ISSN:2414-9314
Container-title:Pediatric Hematology/Oncology and Immunopathology
language:
Short-container-title:Voprosy gematologii/onkologii i immunopatologii v pediatrii

Author:

Kumukova I. B.¹^ORCID,Trakhtman P. E.²^ORCID,Kurnikova E. E.²^ORCID

Affiliation:

1. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation; Kommunarka Multidisciplinary Clinical Center of the Department of Health of Moscow

2. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Abstract

Extracorporeal photopheresis is a method of cell therapy that was developed and introduced into clinical practice of various specialties over 30 years ago but its mechanism of action, clinical application and the possibility of further modification are still on the minds of scientists around the world. Here we provide a review of the existing literature on the major critical aspects of the extracorporeal photopheresis technology as well as information on possible ways of modifying the method, the current understanding of its mechanism of effectiveness, the use in various diseases and pathological conditions and a list of possible side effects.

Publisher

Fund Doctors, Innovations, Science for Children

Subject

Oncology,Hematology,Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Reference37 articles.

1. Gilchrest B. A. Methoxsalen photochemotherapy for mycosis fungoides. Cancer Treat Rep 1979; 63 (4): 663–7.

2. Chuang T. Y., Heinrich L. A., Schultz M. D., Reizner G. T., Kumm R. C., Cripps D. J. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 1992; 26 (2 Pt 1): 173–7. DOI: 10.1016/0190-9622(92)70021-7

3. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316 (6): 297–303. DOI: 10.1056/NEJM198702053160603

4. Yemul S., Berger C., Estabrook A., Suarez S., Edelson R., Bayley H. Selective killing of T lymphocytes by phototoxic liposomes. Proc Natl Acad Sci 1987; 84: 246–50.

5. Gasparro F. P., Psoralen Photochemistry. In Gasparro F. P. (ed.), Extracorporeal Photochemotherapy: Clinical Aspects and the Molecular Basis for Efficacy. CRC Press, Boca Raton, FL; 1994. Rp. 13–36.